Julia M Sheffield1, Sridhar Kandala2, Carol A Tamminga3, Godfrey D Pearlson4, Matcheri S Keshavan5, John A Sweeney6, Brett A Clementz7, Dov B Lerman-Sinkoff8, S Kristian Hill9, Deanna M Barch10. 1. Department of Psychological and Brain Sciences, Washington University, St Louis, Missouri. 2. Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri. 3. Department of Psychiatry and Pediatrics, University of Texas Southwestern Medical Center, Dallas. 4. Departments of Psychiatry and Neurobiology, Yale University, New Haven, Connecticut5Olin Research Center, Institute of Living, Hartford, Connecticut. 5. Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts7Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. 6. Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio. 7. BioImaging Research Center, Department of Psychology, University of Georgia, Athens10BioImaging Research Center, Department of Neuroscience, University of Georgia, Athens. 8. Department of Biomedical Engineering, Washington University, St Louis, Missouri. 9. Department of Psychology, Rosalind Franklin University of Medicine and Science, Chicago, Illinois. 10. Department of Psychological and Brain Sciences, Washington University, St Louis, Missouri2Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri13Department of Radiology, Washington University School of Medicine, St Louis, Missouri.
Abstract
Importance: Cognitive impairment occurs across the psychosis spectrum and is associated with functional outcome. However, it is unknown whether these shared manifestations of cognitive dysfunction across diagnostic categories also reflect shared neurobiological mechanisms or whether the source of impairment differs. Objective: To examine whether the general cognitive deficit observed across psychotic disorders is similarly associated with functional integrity of 2 brain networks widely implicated in supporting many cognitive domains. Design, Setting, and Participants: A total of 201 healthy control participants and 375 patients with psychotic disorders from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium were studied from September 29, 2007, to May 31, 2011. The B-SNIP recruited healthy controls and stable outpatients from 6 sites: Baltimore, Maryland; Boston, Massachusetts; Chicago, Illinois; Dallas, Texas; Detroit, Michigan; and Hartford, Connecticut. All participants underwent cognitive testing and resting-state functional magnetic resonance imaging. Data analysis was performed from April 28, 2015, to February 21, 2017. Main Outcomes and Measures: The Brief Assessment of Cognition in Schizophrenia was used to measure cognitive ability. A principal axis factor analysis on the Brief Assessment of Cognition in Schizophrenia battery yielded a single factor (54% variance explained) that served as the measure of general cognitive ability. Functional network integrity measures included global and local efficiency of the whole brain, cingulo-opercular network (CON), frontoparietal network, and auditory network and exploratory analyses of all networks from the Power atlas. Group differences in network measures, associations between cognition and network measures, and mediation models were tested. Results: The final sample for the current study included 201 healthy controls, 143 patients with schizophrenia, 103 patients with schizoaffective disorder, and 129 patients with psychotic bipolar disorder (mean [SD] age, 35.1 [12.0] years; 281 male [48.8%] and 295 female [51.2%]; 181 white [31.4%], 348 black [60.4%], and 47 other [8.2%]). Patients with schizophrenia (Cohen d = 0.36, P < .001) and psychotic bipolar disorder (Cohen d = 0.33, P = .002) had significantly reduced CON global efficiency compared with healthy controls. All patients with psychotic disorders had significantly reduced CON local efficiency, but the clinical groups did not differ from one another. The CON global efficiency was significantly associated with general cognitive ability across all groups (β = 0.099, P = .009) and significantly mediated the association between psychotic disorder status and general cognition (β = -0.037; 95% CI, -0.076 to -0.014). Subcortical network global efficiency was also significantly reduced in psychotic disorders (F3,587 = 4.01, P = .008) and positively predicted cognitive ability (β = 0.094, P = .009). Conclusions and Relevance: These findings provide evidence that reduced CON and subcortical network efficiency play a role in the general cognitive deficit observed across the psychosis spectrum. They provide new support for the dimensional hypothesis that a shared neurobiological mechanism underlies cognitive impairment in psychotic disorders.
Importance: Cognitive impairment occurs across the psychosis spectrum and is associated with functional outcome. However, it is unknown whether these shared manifestations of cognitive dysfunction across diagnostic categories also reflect shared neurobiological mechanisms or whether the source of impairment differs. Objective: To examine whether the general cognitive deficit observed across psychotic disorders is similarly associated with functional integrity of 2 brain networks widely implicated in supporting many cognitive domains. Design, Setting, and Participants: A total of 201 healthy control participants and 375 patients with psychotic disorders from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium were studied from September 29, 2007, to May 31, 2011. The B-SNIP recruited healthy controls and stable outpatients from 6 sites: Baltimore, Maryland; Boston, Massachusetts; Chicago, Illinois; Dallas, Texas; Detroit, Michigan; and Hartford, Connecticut. All participants underwent cognitive testing and resting-state functional magnetic resonance imaging. Data analysis was performed from April 28, 2015, to February 21, 2017. Main Outcomes and Measures: The Brief Assessment of Cognition in Schizophrenia was used to measure cognitive ability. A principal axis factor analysis on the Brief Assessment of Cognition in Schizophrenia battery yielded a single factor (54% variance explained) that served as the measure of general cognitive ability. Functional network integrity measures included global and local efficiency of the whole brain, cingulo-opercular network (CON), frontoparietal network, and auditory network and exploratory analyses of all networks from the Power atlas. Group differences in network measures, associations between cognition and network measures, and mediation models were tested. Results: The final sample for the current study included 201 healthy controls, 143 patients with schizophrenia, 103 patients with schizoaffective disorder, and 129 patients with psychotic bipolar disorder (mean [SD] age, 35.1 [12.0] years; 281 male [48.8%] and 295 female [51.2%]; 181 white [31.4%], 348 black [60.4%], and 47 other [8.2%]). Patients with schizophrenia (Cohen d = 0.36, P < .001) and psychotic bipolar disorder (Cohen d = 0.33, P = .002) had significantly reduced CON global efficiency compared with healthy controls. All patients with psychotic disorders had significantly reduced CON local efficiency, but the clinical groups did not differ from one another. The CON global efficiency was significantly associated with general cognitive ability across all groups (β = 0.099, P = .009) and significantly mediated the association between psychotic disorder status and general cognition (β = -0.037; 95% CI, -0.076 to -0.014). Subcortical network global efficiency was also significantly reduced in psychotic disorders (F3,587 = 4.01, P = .008) and positively predicted cognitive ability (β = 0.094, P = .009). Conclusions and Relevance: These findings provide evidence that reduced CON and subcortical network efficiency play a role in the general cognitive deficit observed across the psychosis spectrum. They provide new support for the dimensional hypothesis that a shared neurobiological mechanism underlies cognitive impairment in psychotic disorders.
Authors: Julia M Sheffield; Sridhar Kandala; Gregory C Burgess; Michael P Harms; Deanna M Barch Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2016-11
Authors: Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore Journal: J Affect Disord Date: 2006-03-06 Impact factor: 4.839
Authors: Justin T Baker; Avram J Holmes; Grace A Masters; B T Thomas Yeo; Fenna Krienen; Randy L Buckner; Dost Öngür Journal: JAMA Psychiatry Date: 2014-02 Impact factor: 21.596
Authors: Carol A Tamminga; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Bradley Witte; David W Morris; Jeffrey Bishop; Gunvant K Thaker; John A Sweeney Journal: Am J Psychiatry Date: 2013-11 Impact factor: 18.112
Authors: Lotta-Katrin Pries; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Rajiv Radhakrishnan; Maarten Bak; Bart P F Rutten; Jim van Os Journal: Schizophr Bull Date: 2018-06-06 Impact factor: 9.306
Authors: Jie Lisa Ji; Caroline Diehl; Charles Schleifer; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney; Brett A Clementz; S Kristian Hill; Godfrey Pearlson; Genevieve Yang; Gina Creatura; John H Krystal; Grega Repovs; John Murray; Anderson Winkler; Alan Anticevic Journal: Cereb Cortex Date: 2019-12-17 Impact factor: 5.357
Authors: Julia M Sheffield; Baxter P Rogers; Jennifer U Blackford; Stephan Heckers; Neil D Woodward Journal: Biol Psychiatry Date: 2019-01-04 Impact factor: 13.382
Authors: Jason Smucny; Tyler A Lesh; Keith Newton; Tara A Niendam; J Daniel Ragland; Cameron S Carter Journal: Neuropsychopharmacology Date: 2017-09-26 Impact factor: 7.853
Authors: Dov B Lerman-Sinkoff; Sridhar Kandala; Vince D Calhoun; Deanna M Barch; Daniel T Mamah Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2019-05-20
Authors: Paolo Fusar-Poli; Marco Solmi; Natascia Brondino; Cathy Davies; Chungil Chae; Pierluigi Politi; Stefan Borgwardt; Stephen M Lawrie; Josef Parnas; Philip McGuire Journal: World Psychiatry Date: 2019-06 Impact factor: 49.548